Assessment of dual inhibition property of newly discovered inhibitors against PCAF and GCN5 through in silico screening, molecular dynamics simulation and DFT approach

References

• Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002;12:142–8
   PubMed Web of Science ®Google Scholar
• Kouzarides T. Chromatin modifications and their function. Cell 2007;128:693–705
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403:41–5
   PubMed Web of Science ®Google Scholar
• Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005;15:163–76
   PubMed Web of Science ®Google Scholar
• Biel M, Wascholowski V, Giannis A. Epigenetics – an epicenter of gene regulation: histones and histone-modifying enzymes. Angew Chem Int E 2005;44:3186–216
   PubMed Web of Science ®Google Scholar
• Yang X. The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 2004;32:959–76
   PubMed Web of Science ®Google Scholar
• Vetting MW, de Carvalho LPS, Yu M, et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys 2005;433:212–16
   PubMed Web of Science ®Google Scholar
• Schiltz RL, Mizzen, CA Vassilev A, et al. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem 1999;274:1189–92
   PubMed Web of Science ®Google Scholar
• Heery DM, Fischer PM. Pharmacological targeting of lysine acetyltransferases in human disease: a progress report. Drug Discov Today 2007;12:88–99
   PubMed Web of Science ®Google Scholar
• Cheung P, Tanner KG, Cheung WL, et al. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 2000;5:905–15
   PubMed Web of Science ®Google Scholar
• Howe L, Auston D, Grant P, et al. Histone H3 specific acetyltransferases are essential for cell cycle. Genes Dev 2001;15:3144–54
   PubMed Web of Science ®Google Scholar
• Ionov Y, Matsui S, Cowell JK. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA 2004;101:1273–8
   PubMed Web of Science ®Google Scholar
• Seligson DB, Horvath S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005;435:1262–6
   PubMed Web of Science ®Google Scholar
• Seligson DB, Horvath S, McBrian MA, et al. Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 2009;174:1619–28
   PubMed Web of Science ®Google Scholar
• Schiltz RL, Nakatani Y. The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta 2000;1470:M37–53
   PubMed Web of Science ®Google Scholar
• Balasubramanyam K, Varier RA, Altaf M, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004;279:51163–71
   PubMed Web of Science ®Google Scholar
• Nagy Z, Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global acetylation. Oncogene 2007;26:5341–57
   PubMed Web of Science ®Google Scholar
• Howe L, Auston D, Grant P, et al. Histone H3 specific acetyltransferases are essential for cell cycle progression. Genes Dev 2001;15:3144–54
   PubMed Web of Science ®Google Scholar
• Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today 2009;14:942–8
   PubMed Web of Science ®Google Scholar
• Bhalla KN. Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies. J Clin Oncol 2005;23:3971–93
   PubMed Web of Science ®Google Scholar
• Clerici F, Contini A, Gelmi ML, Pocar D. New 3-aminosubstituted isothiazole dioxides and their mono- and dihalogeno derivatives. Tetrahedron 2003;59:9399–408
   Web of Science ®Google Scholar
• Dekker FJ, Ghizzoni M, Van der Meer N, et al. Inhibition of the PCAF histone acetyl transferase and cell proliferation by isothiazolones. Bioorg Med Chem 2009;17:460–6
   PubMed Web of Science ®Google Scholar
• Dixon SL, Smondyrev AM, Knoll EH, et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 2006;20:647–71
   PubMed Web of Science ®Google Scholar
• Jain SV, Sonawane LV, Patil RR, Bari SB. Pharmacophore modeling of some novel indole b-diketo acid and coumarin based derivatives as HIV integrase inhibitors. Med Chem Res 2010;21:165–73
   Web of Science ®Google Scholar
• Phase. Version 3.4.New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• LigPrep. Version 2.5. New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• Suryanarayanan V, Sudha A, Rajamanikandan S, et al. Atom-based 3D QSAR studies on novel N-β-d-xylosylindole derivatives as SGLT2 inhibitors. Med Chem Res 2013;22:615–24
   Web of Science ®Google Scholar
• Suryanarayanan V, Singh SK, Tripathi SK, et al. A three-dimensional chemical phase pharmacophore mapping, QSAR modeling and electronic feature analysis of benzofuran salicylic acid derivatives as LYP inhibitors. SAR QSAR Environ Res 2013;24:1025–40
   PubMed Web of Science ®Google Scholar
• Reddy KK, Singh SK, Dessalew N, et al. Pharmacophore modeling and atom based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors. J Enzym Inhib Med Ch 2012;27:339–47
   PubMed Web of Science ®Google Scholar
• Sakkiah S, Thangapandian S, John S, Lee KW. Pharmacophore based virtual screening, molecular docking studies to design potent heat shock protein 90 inhibitors. Eur J Med Chem 2011;46:2937–47
   PubMed Web of Science ®Google Scholar
• John S, Thangapandian S, Sakkiah S, Lee KW. Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies. BMC Bioinformatics 2011;12:S28
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49
   PubMed Web of Science ®Google Scholar
• Protein Preparation Wizard. New York, NY: Schrödinger, LLC;2012
   Google Scholar
• Maestro. Version 9.3. New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• Prime. Version 3.1. New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• Hou TJ, Wang J, Li YY, Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J Comput Chem 2011;32:866–77
   PubMed Web of Science ®Google Scholar
• Lyne PD, Lamb ML, Saeh JC. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 2006;16:4805–8
   Web of Science ®Google Scholar
• Das D, Koh Y, Tojo Y, et al. Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model. J Chem Inf Model 2009;12:2851–62
   Web of Science ®Google Scholar
• Budha NR, Mehrotra N, Tangallapally R, et al. Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agents. AAPS J 2008;10:157–65
   PubMed Web of Science ®Google Scholar
• Desmond. Version 3.1. New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J Phys Chem B 2001;105:6474–87
   Web of Science ®Google Scholar
• Jorgensen WL, Chandrasekhar J, Madura JD, et al. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926–35
   Web of Science ®Google Scholar
• Jaguar. Version 7.9.New York, NY: Schrödinger, LLC; 2012
   Google Scholar
• Bhattacharjee AK, Gordon JA, Marek E, et al. 3D-QSAR studies of 2,2-diphenylpropionates to aid discovery of novel potent muscarinic antagonists. Bioorg Med Chem 2009;17:3999–4012
   PubMed Web of Science ®Google Scholar
• Paulino M, Alvareda EM, Denis PA, et al. Studies of trypanocidal (inhibitory) power of naphthoquinones: evaluation of quantum chemical molecular descriptors for structure-activity relationships. Eur J Med Chem 2008;43:2238–46
   PubMed Web of Science ®Google Scholar
• Eroglu E, Türkmen H. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II. J Mol Graph Model 2007;26:701–8
   PubMed Web of Science ®Google Scholar
• Szaleniec M, Witko M, Tadeusiewicz R, Goclon J. Application of artificial neural networks and DFT-based parameters for prediction of reaction kinetics of ethylbenzene dehydrogenase. J Comput Aided Mol Des 2006;20:145–57
   PubMed Web of Science ®Google Scholar
• Tawari NR, Degani MS. Pharmacophore mapping and electronic feature analysis for a series of nitroaromatics compounds with antitubercular activity. J Comput Chem 2010;31:739–51
   PubMed Web of Science ®Google Scholar
• Tawari NR, Degani MS. Pharmacophore modeling and density functional theory analysis for a series of nitroamidazole compounds with antitubercular activity. Chem Biol Drug Des 2011;78:408–17
   PubMed Web of Science ®Google Scholar
• Naik PK, Santoshi S, Joshi HC. Noscapinoids with anti-cancer activity against human acute lymphoblastic leukemia cells (CEM): a three dimensional chemical space pharmacophore modeling and electronic feature analysis. J Mol Model 2012;18:307–18
   PubMed Web of Science ®Google Scholar